The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture

被引:118
作者
Linde, K
Jonas, WB
Melchart, D
Willich, S
机构
[1] Tech Univ Munich, Dept Internal Med 2, Ctr Complementary Med Res, D-80801 Munich, Germany
[2] Humboldt Univ, Inst Social Med & Epidemiol, Berlin, Germany
[3] Uniformed Serv Univ Hlth Sci, Dept Family Med, Bethesda, MD 20814 USA
关键词
alternative medicine; homeopathy; acupuncture; Hypericum; Echinacea; controlled clinical trials; randomized controlled trials; meta-analysis;
D O I
10.1093/ije/30.3.526
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background To investigate the methodological quality of randomized controlled trials in three areas of complementary medicine. Methods The methodological quality of 207 randomized trials collected for five previously published systematic reviews on homeopathy, herbal medicine (Hypericum for depression, Echinacea for common cold), and acupuncture (for asthma and chronic headache) was assessed using a validated scale (the Jadad scale) and single quality items. Results While the methodological quality of the trials was highly variable, the majority had important shortcomings in reporting and/or methodology. Major problems in most trials were the description of allocation concealment and the reporting of drop-outs and withdrawals. There were relevant differences in single quality components between the different complementary therapies: For example, acupuncture trials reported adequate allocation concealment less often (6% versus 32% of homeopathy and 26% of herb trials), and trials on herbal extracts had better summary scores (mean score 3.12 versus 2.33 for homeopathy and 2.19 for acupuncture trials). Larger trials published more recently in journals listed in Medline and in English language scored significantly higher than trials not mecting these criteria. Conclusion Trials of complementary therapies often have relevant methodological weaknesses. The type of weaknesses varies considerably across interventions.
引用
收藏
页码:526 / 531
页数:6
相关论文
共 26 条
[1]  
[Anonymous], COMPLEMENT THER MED
[2]  
Assendelft W J, 1996, J Manipulative Physiol Ther, V19, P499
[3]   Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].
Begg, C ;
Cho, M ;
Eastwood, S ;
Horton, R ;
Moher, D ;
Olkin, I ;
Pitkin, R ;
Rennie, D ;
Schulz, KF ;
Simel, D ;
Stroup, DF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639
[4]  
BLOOM BS, 1998, BEST EVIDENCE ALTERN
[5]   Language bias in randomised controlled trials published in English and German [J].
Egger, E ;
ZellwegerZahner, T ;
Schneider, M ;
Junker, C ;
Lengeler, C ;
Antes, G .
LANCET, 1997, 350 (9074) :326-329
[6]   Trends in alternative medicine use in the United States, 1990-1997 - Results of a follow-up national survey [J].
Eisenberg, DM ;
Davis, RB ;
Ettner, SL ;
Appel, S ;
Wilkey, S ;
van Rompay, M ;
Kessler, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18) :1569-1575
[8]   Assessing the quality of reports of randomized clinical trials: Is blinding necessary? [J].
Jadad, AR ;
Moore, RA ;
Carroll, D ;
Jenkinson, C ;
Reynolds, DJM ;
Gavaghan, DJ ;
McQuay, HJ .
CONTROLLED CLINICAL TRIALS, 1996, 17 (01) :1-12
[9]   The hazards of scoring the quality of clinical trials for meta-analysis [J].
Jüni, P ;
Witschi, A ;
Bloch, R ;
Egger, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (11) :1054-1060
[10]   The importance of quality of primary studies in producing unbiased systematic reviews [J].
Khan, KS ;
Daya, S ;
Jadad, AR .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (06) :661-666